The novel class of GLP-1 receptor and GIP dual medications, like tirzepatide, semaglutide, and the newly introduced retatrutide, represent promising progress in the treatment . While all three work by https://semaglutide621266.blogmazing.com/42425029/tirzepatide-one-comparative-examination